A new synthetic route is proposed for the synthesis of 3,6-dimethyl-6-aryl-1,5,6,7-tetrahydro-8H-pyrazolo[3',4':4,5]thieno [2,3-d]pyrimidin-8-ones 3a-h from 5-amino-3-methyl-1H-thieno[3,2-c]pyrazole-6-carbonitrile 2. Synthesis of the key compound 2 was accomplished via a Gewald reaction. The newly synthesized compounds 3a-h were characterized by elemental analysis, IR, 1 H-NMR, 13 C-NMR and mass spectroscopic investigation. All the compounds 3a-h were screened for their antitubercular activity against Mycobacterium tuberculosis H 37 RV.
Introduction
Pyrazole containing compounds have practical applications in the medicinal and agrochemical field and the biological activity of pyrazoles 1, 2 and its derivatives are well documented. The pyrazole ring has shown to be the basic moiety for a number of dyes and drugs 3, 4 . Substituted pyrazolopyrimidinones are found to be useful as cardiotonic, 5 herbicidal 6 and antiviral 7 agents.
Literature survey reveals that substituted pyrazolopyrimidinones are potent and selective inhibitors of type 5 cyclic guanosine-3´, 5´-monophosphate phosphodiesterase (cGMP) PDE-5 8, 9 and, as such, have utility in the treatment of male erectile dysfunction (MED) and female sexual dysfunction (FSD) 10 . C-6 substituted pyrimidinone and pyrimidindione derivatives have shown selective antitumor, 11 antiviral, 12 antitubercular 13 and antifungal activity 14 . The above mentioned references suggest the importance of testing this family of compounds as broad-spectrum drugs.
In search of bioactive molecules and in continuation of our previous work [15] [16] [17] [18] in developing syntheses of polyfunctionally substituted heterocyclic compounds, we report a novel synthetic approach for the synthesis of 3,6-dimethyl-6-aryl-1,5,6,7-tetrahydro-8H- 
Results and Discussion
Synthesis of 5-amino-3-methyl-1H-thieno[3,2-c]pyrazole-6-carbonitrile 2 was accomplished by refluxing (5-methyl-2,4-dihydro-3H-pyrazol-3-ylidene)malononitrile 1 and sulfur in the presence of morpholine for 6 hrs. The IR spectrum of 2 revealed the appearance of bands characteristics of stretching vibrations of 3420-3305 cm -1 (-NH 2 ), 2234 cm -1 (-CN), 1645 cm -1 (C=N) groups. C NMR spectra exhibited confirmatory signals of the carbonyl carbon and the methyl carbon around δ 164 and δ 28 respectively.
Biological activity
The in vitro antimycobacterial activity was assayed by the Tuberculosis Antimicrobial Acquisition Coordinating Facility (TAACF) antituberculosis drug discovery program, coordinated by the Southern Research Institute (Birmingham, Ala.) under the direction of the National Institute of Allergy and Infectious Diseases, U.S.A. All the compounds (3a-h) were initially screened against Mycobacterium tuberculosis H 37 RV (ATCC 27294) (American Type Culture Collection, Manassas, Va.) at the single concentration of 6.25 µg/ml in BACTEC 12B medium using a broth micro dilution assay, the microplate Alamar blue assay (MABA) 25 .
Compounds exhibiting fluorescence were tested in the BACTEC 460 radiometric system 26 .
Compounds demonstrating at least 90% inhibition in the primary screening were retested at lower concentrations by serial dilution against Mycobacterium tuberculosis H 37 RV to determine the actual MIC, using the micro plate alamar blue assay (MABA) method. Concurrent with the determination of MICs, compounds were tested for cytotoxicity (50% inhibitory concentration [IC 50 ]) in Vero cell line to determine the selectivity index (SI), defined as the ratio of the measured IC50 in VERO cells to the MIC values. Compound 3d showed a MIC value of 3.13 µg/ml, IC50 value of 1.660 and SI of 0.5322. The results of antitubercular activities are represented in Table 1 . The present study on the synthesis and biological screening of some novel pyrazolo 
Experimental Section
General Procedures. Melting points were determined in open capillaries and are uncorrected. The IR spectra were recorded on Nicolet Impact 410 FT IR spectrophotometer using KBr pellets. 1 H and 13 C NMR spectra were recorded on Bruker 300-MHz FT NMR spectrometer in CDCl 3 and DMSO-d6 with TMS as an internal standard. Mass spectra were recorded on ThermoFinnigan-MAT, Bremen (Model MAT8200) spectrometer and elemental analysis was carried out using Heraus CHN rapid analyzer. All chemicals were purchased from Aldrich Chemical Company (USA) and were used as received unless otherwise noted. Solvents used for the chemical synthesis were of laboratory and analytical grade, and were used without further purification.
Preparation of (5-methyl-2,4-dihydro-3H-pyrazol-3-ylidene)malononitrile (1). A mixture of 5-methyl-2,4-dihydro-3H-pyrazol-3-one (0.98 g, 0.01 mol) and malononitrile (66 mL, 0.01 mol) was heated under reflux condition for 6 hours in the presence of piperidyl acetate in a catalytic amount. The reaction mixture was poured into ice cold water; the crude product was filtered, dried and recrystallized from 95 % ethanol. Yield 52%, mp. 
Preparation of 5-amino-3-methyl-1H-thieno[3,2-c]pyrazole-6-carbonitrile (2).
A mixture of (5-methyl-2,4-dihydro-3H-pyrazol-3-ylidene)malononitrile 1 (1.46 g, 0.01 mol) and sulfur (0.32 g, 0.01 mol) was heated under reflux condition in the presence of morpholine (0.87 mL) for 6 hours. The reaction mixture was poured into ice cold water; the crude product was filtered, dried and recrystallized from 95 % ethanol. Yield 58%, mp. 6-(4-Bromophenyl)-3,6-dimethyl-1,5,6,7-tetrahydro-8H-pyrazolo[3',4 
